Preventing cancer therapy-related heart failure: the need for novel studies

Conclusion Only concomitant statin and angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapies were associated with significantly lower risk of anticancer therapy-related heart failure.
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Research articles: Cardiotoxicity Source Type: research